Art

J-GLOBAL ID：202102230508101871   Reference number：21A0295118

Recent advances in the management of anaplastic thyroid cancer

未分化甲状腺癌の管理における最近の進歩【JST・京大機械翻訳】

Author (4)： Leo Simone De (Department of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy) ,  Trevisan Matteo (Department of Pathophysiology and Transplantation, Universita degli Studi di Milano, Milan, Italy) ,  Fugazzola Laura (Department of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy) ,  Fugazzola Laura (Department of Pathophysiology and Transplantation, Universita degli Studi di Milano, Milan, Italy)
Material： Thyroid Research (Web)
Volume： 13  Issue： 1  Page： 1-14  Publication year： 2020 
JST Material Number： U7554A  ISSN： 1756-6614  Document type： Article
Article type： 文献レビュー  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Abstract/Point： Anaplastic thyroid cancer (ATC...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=21A0295118&from=J-GLOBAL&jstjournalNo=U7554A") }}

Thesaurus term： tumor ,  mutation ,  radiotherapy ,  immunotherapy ,  cisplatin ,  targeting ,  *thyroid tumor ,  angiogenesis ,  carboplatin ,  amino sugar ,  quinone ,  glycoside(except carbohydrate) ,  polyphenol ,  deoxysugar ,  pyranoside ,  phenol ether ,  polynuclear aromatic compound ,  hydroxy ketone ,  polyol
Semi thesaurus term： 蛋白質キナーゼ阻害剤 ,  予後不良 ,  チロシンキナーゼ阻害剤 ,  過剰発現 , 【Automatic Indexing@JST】

Author keywords (6)： Anaplastic Thyroid Cancer ,  Treatment ,  Tyrosine-kinase Inhibitors ,  Immunotherapy ,  Immune Checkpoint Inhibitors ,  Targeted Therapy

JST classification (3)： Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Clinical application of antitumor(=antineoplastic)drugs  (GW16020L) ,  Tumors(=neoplasms)of respiratory system  (GI04000G)

Substance index (2)： Imatinib ,  Doxorubicin

Reference (112)：

• Clin Oncol; Anaplastic thyroid carcinoma: Pathogenesis and emerging therapies; RC Smallridge, JA Copland; 22; 2010; 486-97; 10.1016/j.clon.2010.03.013; citation_id=CR1
• Thyroid; Thyroid Cancer Incidence Trends in the United States: Association with Changes in Professional Guideline Recommendations; M Pereira, VL Williams, J Hallanger Johnson, P Valderrabano; 2020; 10.1089/thy.2019.0415; citation_id=CR2
• Endocr Rev; Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond; ME Cabanillas, M Ryder, C Jimenez; 40; 2019; 1573-604; 10.1210/er.2019-00007; citation_id=CR3
• Thyroid; Updated American joint committee on cancer/tumor-node-metastasis staging system for differentiated and anaplastic thyroid cancer (Eighth Edition): What changed and why?; RM Tuttle, B Haugen, ND Perrier; 27; 2017; 751-6; 10.1089/thy.2017.0102; citation_id=CR4
• Cancers; Evaluation of the 8th edition TNM classification for anaplastic thyroid carcinoma; N Onoda, I Sugitani, KI Ito, A Suzuki, T Higashiyama, T Fukumori; 12; 2020; 1-11; 10.3390/cancers12030552; citation_id=CR5

Terms in the title (1)： 未分化甲状腺癌